"Designing Growth Strategies is in our DNA"

Optometry Equipment Market Size, Share, and Industry Analysis By Product (Refractor, Slit Lamps, Retinal Camera, Tonometer, Optical Imaging, Lensometer, and Others), By Application (Cataract, Glaucoma, Refractive Errors, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Regional Forecast till 2032

Region : Global | Report ID: FBI112526 | Status : Ongoing

 

KEY MARKET INSIGHTS

The global optometry equipment market size was valued at USD 4.24 billion in 2024. The market is projected to grow from USD 4.56 billion in 2025 to USD 7.57 billion by 2032, exhibiting a CAGR of 5.71% during the forecast period.

The global optometry equipment market is estimated to grow significantly. It is driven by the growing incidence of eye diseases and disorders. The optometry equipment is a medical tool. It is used to check visual system disorders and abnormalities related to the eye. Optometrists use devices to manage and diagnose problems with vision.

  • According to the Agency for Healthcare Research and Quality (AHRQ), the average number of OCT units per hospital is 3 units in the U.S. in 2023.

Visual field analyzers, retinoscopes, fundua camera, autorefractors, and other devices are included in instrument. This instrument is offering effective and high-quality eye treatment worldwide. It is extensively used in hospitals and clinics.

  • According to the American Optometric Association (AOA), approximately 41500 were licensed vision care clinics in the U.S. in 2023.

Optometry Equipment Market Driver

Increasing Prevalence of Eye Disorders and Government Initiatives and Reimbursement Policies Impel Market Growth

The growing factor for market expansion is the increasing rate of incidence of eye disorders. An increasing number of people are expected to suffer from these conditions with an aging population, increasing demand for diagnosis instruments and treatments. Moreover, growing numbers of diabetes patients who are prone to develop diabetic retinopathy contribute to market expansion. Technological progress that has resulted in creation of non-invasive and highly precise diagnostic devices is also boosting market growth.

  • According to the Sante Publique France, approximately 5200000 diagnostic procedures used the tool in France in 2023.

Furthermore, government initiatives by various regions are propelling market growth. A number of organizations across the world are initiating programs that present low-cost or free screenings and treatment to aid deprived sections of society. Furthermore, the presence of favorable reimbursement policies for vision care procedures is stimulating service providers to spend on new technology and implement such devices.

  • According to the National Health Portal (NHP), about 520 units of portable tools were approved in rural clinics by India in 2023.

Optometry Equipment Market Restraint

High Cost of Equipment and Regulatory Compliance and standards Hinder Market Growth

The limiting factor for market impediment is high cost of products. The huge initial cost associated with advanced eye exam devices can be a barrier, especially for small clinics and practices. Cost-effective solutions and financing options are essential to overcome this obstacle.

Furthermore, compliance with diverse international regulations and standards for medical devices obstruct market growth. Manufacturers must empower in agreement and quality assurance to cater market requirements. In addition, fast changing technological advancements are making shorter product life, hence hampering market expansion.

Optometry Equipment Market Opportunity

Integration of AI and Tele-Optometry Solutions Create Opportunity for Market Growth

One of the most significant opportunities for market expansion is incorporation of advanced technologies for instance artificial intelligence and machine learning into tools. These encroachments into diagnostic devices are offering more accurate and efficient detection tools. The development of portable and handheld devices is also making eye care more accessible, especially in remote and underserved areas.

  • According to the National Natural Science Foundation of China (NSFC), China initiated about 152 R&D projects on AI-based eye diagnostics in 2023.

Furthermore, increasing use of telemedicine platforms for remote eye examinations is presenting a new avenue for market growth. The incorporation of such services into telemedicine platforms allows remote eye exams, especially for individuals in remote areas. The growth of telemedicine broadens market reach for exam equipment.

Segmentation

By Product

By Application

By End-user

By Geography

· Refractor

· Slit Lamps

· Retinal Camera

· Tonometer

· Optical Imaging

· Lensometer

· Others

· Cataract

· Glaucoma

· Refractive Errors

· Others

· Hospitals

· Specialty Clinics

· Others

· North America (U.S. and Canada)

· Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe)

· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

· Latin America (Brazil, Mexico, and the Rest of Latin America)

· Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)

Key Insights

The report covers the following key insights:

  • Increasing Incidence of Eye Disorders among Population by Key Countries
  • Incorporation of AI and Tele-Optometry Solutions into devices by Key Companies
  • Drivers, Restraints, Trends, and Opportunities
  • Business Strategies Adopted by Key Players
  • Consolidated SWOT Analysis of Key Players
  • Key Industry Developments (Mergers, Acquisitions, Partnerships)

Analysis by Product

Based on product, the optometry equipment market is divided into refractor, slit lamps, retinal camera, tonometer, optical imaging, lensometer, and others.

The retinal camera segment is leading in the market, driven by extensive practice of this product for general examination of the eye disease. Rising number of new product launches by countries are impelling segment growth.

The refractor segment is gaining traction in the market, caused by use of these devices to measure refractive power of the eye, helping determine the need for corrective lenses.

Analysis by Application

Based on application, the optometry equipment market is divided into cataract, glaucoma, refractive errors, and others.

The cataract segment is leading in the market, driven by high acceptance of devices for such surgeries. Increasing rate incidence of these disorders among individuals is impelling market growth.

The refractive disorders segment is anticipated to grow in the market, caused by rising far-distance vision impairment among people. Rising introduction of advanced diagnosis and treatment is boosting segment expansion.

Analysis by End-user

Based on end-user, the optometry equipment market is divided into hospitals, specialty clinics, and others.

The hospital segment is dominating in the market, caused by escalating adoption of devices and offering of low-cost and effective treatments. Increasing alliances between ophthalmic clinics and hospitals is raising demand for new installations.

The specialty clinics segment is projected to grow in the market, caused by intensifying demand for eye care. Systematic investigations are required to identify probable implications for security and quality of medical services that are impelling demand for segments.

Regional Analysis

Based on geography, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

To gain extensive insights into the market, Download for Customization

North America is the dominating region in the market, driven by entrenched healthcare infrastructure. High awareness about eye health and an aging population are impelling demand for services and instruments. Rising expenditure in advanced diagnostic technologies and a high prevalence of eye diseases are supporting market growth.

Europe is witnessing considerable growth in the market, caused by augmented incidence of myopia in young people and children. They are raising demand for tools in this region. Rising commercial activity in developing optical consistency tomography devices, as well as augmented product releases in the region, are bolstering market expansion. Rising involvement of advanced technology into the system is fostering market growth.

The Asia Pacific region is the fastest growing region in the market owing to the hasty improvement of the healthcare sector. Growing number of optometrists and ophthalmic clinics is fostering acceptance of instruments and as a result propelling market growth in this region. Rapid urbanization and aging populations are bolstering the requirement of instruments. Growing consciousness of eye health among individuals is supporting market growth.

Key Players Covered

The report includes the profiles of the following key players:

  • ZEISS Group (Germany)
  • TOPCON CORPORATION (Japan)
  • EssilorLuxottica (France)
  • Bausch Health Companies Inc. (Canada)
  • Alcon (Switzerland)
  • NIDEK CO., LTD. (Japan)
  • Oculus Inc. (U.S.)
  • Halma PLc (U.K.)

Key Industry Developments

  • In September 2023, Bausch + Lomb announced acquisition of AcuFocus, manufacturer of IC-8 Apthera Intraocular Lens to augment its cataract surgical range.
  • In February 2021, Carl Zeiss AG unveiled BlueGuard blue light blocking lenses. The purpose of this new product is to address increased dependence on digital devices and requirements for eye protection.
  • In June 2020, Topcon Healthcare launched its new product the MYAH instrument in Europe. It is a wide-ranging management tool for myopia and dry eye services.


  • Ongoing
  • 2024
  • 2019-2023
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann